More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.


An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approving Alkermes Plc's treatment for depression in patients with an inadequate response to standard antidepressant therapies.

Through a scan of social media posts, an algorithm was able to predict which individuals were later diagnosed with depression, according to a study published online.

In a small group of patients with major depressive disorder and symptoms of insomnia, treatment with the antidepressant vortioxetine significantly improved depression and sleep issues.

ORLANDO, Fla.—Data on esketamine nasal spray, focusing on efficacy, tolerability, and predictors of response and remission, were presented in 4 poster abstracts at Psych Congress 2018.

ORLANDO, Fla.—Mental health clinicians should avoid antidepressants in patients with depressive symptoms that coexist with symptoms of mania, Joseph F. Goldberg, MD, advised attendees at Psych Congress 2018.



BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to infectious disease.

I’m in London interviewing loved ones of doctors who have ended their lives by suicide.

We need to get the message out that for every death by suicide there is a cohort of bereaved family members who themselves become ill and suicidal. They require — and deserve — our best diagnostic and treatment efforts.



Benjamin Carroll, PharmD; Paul Juneau, MS; Debra Irwin, MD, MSPH
Emily McNaughton, MPH; Jamie Granskie, BS; Christopher Curran, BS; Mark Opler, MPH, PhD; Sara Sarkey, PhD; Jen Schuster, BS; Lisa Mucha, PhD; Anna Eramo, MD; Clement Francois, PhD Health Economics; Brianna Webber-Lind, MS, PsyD
Gordon Loewen, PhD; Rosa Luo, EM; Evan Smith, BS; Grace Liang, PhD; Khodayar Farahmand, PharmD; Haig Bozigian, PhD; Christopher OкBrien, MD
Hubert Fernandez, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Karen Anderson, MD
Mary Hobart, PhD; Aleksandar Skuban, MD; Peter Zhang, PhD; Mette Krog Josiassen, MA; Nanco Hefting, MSc; Claudette Brewer, BA; Ray Sanchez, MD; Robert McQuade, PhD



Psych Congress Steering Committee members Jon W. Draud, MD, MS, and Saundra Jain, MA, PsyD, LPC, discuss some of the practical aspects of setting up a transcranial magnetic stimulation (TMS) chair in a practice.

Psych Congress Steering Committee members Jon W. Draud, MD, MS, and Saundra Jain, MA, PsyD, LPC, discuss the use of transcranial magnetic stimulation (TMS) on patients with treatment-resistant depression.

Gerard Sanacora, MD, PhD, and Charles Raison, MD, talk about considerations surrounding the decision to prescribe ketamine, an experimental therapeutic, to patients struggling with depression.